Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines
eJHaem · 2025-12 · 6 (6)
DOI: 10.1002/jha2.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 28.11.2025. Verfasst von Michelle A E Brouwer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Haematology Amphia Hospital Breda the Netherlands. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Specific granule deficiency type II (SGD2) is a rare heterogeneous congenital disease characterized by early‐onset life‐threatening infections. SGD2 is caused by autosomal recessive mutations in the SMARCD2 gene.
Methods
Prenatal screening in our patient revealed a novel homozygous nonsense mutation in SMARCD2 (c.208C>T, p.Gln70*).
Results
Postnatally, she suffered from infections, pneumonia, cholestasis, mucocutaneous bleeding, and dysmorphic features, including clubfoot. Hematological findings included neutropenia, monocytosis, myelodysplasia, and thrombocytopenia. In contrast to previous cases, this patient presented with dysplasia of all myeloid lineages, including hypogranular neutrophils, pseudo Pelger–Huët, macrothrombocytes, bilobular monocytes, and dysplastic erythroblasts. Due to the severity of her condition, she passed away after 1.5 months.
Conclusion
This report illustrates the role of SMARCD2 in hematopoiesis and provides an overview of all previously described SGD2 patients. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
Autor:innen und Institutionen
- Department of Clinical Chemistry and Haematology Amphia Hospital Breda the Netherlands.
- Department of Pediatrics Amphia Hospital Breda the Netherlands.
- Department of Neonatal and Pediatric Intensive Care Division of Neonatology Erasmus MC Sophia Children's Hospital Rotterdam the Netherlands.
- Department of Pediatrics Pediatric Stem Cell Transplantation Program Willem-Alexander Children's Hospital Leiden University Medical Center Leiden the Netherlands.
- Department of Clinical Genetics Maastricht University Medical Centre (MUMC+) Maastricht the Netherlands.
ORCID-Profile: Michelle A E Brouwer
Zitieren
APA
Brouwer, M. A. E., Arensman, A., Taal, H. R., Buddingh, E. P., Sun, S. M., Hulsmann, A., & Waals-Prinzen, L. (2025). Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines. eJHaem, 6(6). https://doi.org/10.1002/jha2.70194
Vancouver
Brouwer MAE, Arensman A, Taal HR, Buddingh EP, Sun SM, Hulsmann A, et al. Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines. eJHaem. 2025;6(6). doi:10.1002/jha2.70194
BibTeX
@article{Brouwer2025,
author = {Brouwer, Michelle A E and Arensman, Arie and Taal, H Rob and Buddingh, Emilie P and Sun, Su Ming and Hulsmann, Anthon and Waals-Prinzen, Lenneke},
title = {Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines},
journal = {eJHaem},
year = {2025},
volume = {6},
number = {6},
doi = {10.1002/jha2.70194}
}
EUVIMED